false
OasisLMS
Catalog
SCCM Resource Library
Effect of ICU Therapeutics in Older Adults: COVID ...
Effect of ICU Therapeutics in Older Adults: COVID and Beyond
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, the speaker discusses challenges with pharmacotherapy in critically ill elderly patients. They highlight that the elderly population is growing and that these patients often have comorbidities and are more vulnerable to poor outcomes. They discuss the relationship between frailty and outcomes such as delirium, hospital length of stay, and mortality. The speaker also emphasizes the importance of medication optimization in the ICU, considering factors such as changes in fluid status, renal or hepatic function, and pharmacokinetics and dynamics in the elderly. They discuss the impact of sedatives and analgesics on outcomes, such as delirium and cognitive function, and highlight the need for minimizing these medications and implementing best practices. They also discuss considerations for antimicrobial therapy, including dose adjustments and pharmacodynamics. The speaker concludes by discussing the challenges of polypharmacy in the ICU and the importance of appropriate prescribing and deprescribing, including the use of interventions such as electronic decision support.
Asset Subtitle
Neuroscience, 2023
Asset Caption
Type: one-hour concurrent | Care of the Older ICU Patient in the COVID Era and Beyond (SessionID 1192501)
Meta Tag
Content Type
Presentation
Knowledge Area
Neuroscience
Learning Pathway
Delirium and Sedation Managment
Membership Level
Professional
Membership Level
Select
Tag
Delirium
Year
2023
Keywords
pharmacotherapy
elderly patients
frailty
medication optimization
ICU
polypharmacy
×
Please select your language
1
English